| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61719-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61860-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61798-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89187-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-99331-50ul | |||
![Western Blot: Bub1 Antibody (1A11C7) [NBP2-61719] - Analysis using BUB1 mAb against human BUB1 (AA: 1-130) recombinant protein. (Expected MW is 41.3 kDa)](http://images.novusbio.com/fullsize/Bub1-Antibody-1A11C7-Western-Blot-NBP2-61719-img0003.jpg "Western Blot: Bub1 Antibody (1A11C7) [NBP2-61719] - Analysis using BUB1 mAb against human BUB1 (AA: 1-130) recombinant protein. (Expected MW is 41.3 kDa)")
![Flow Cytometry: Bub1 Antibody (1A11C7) [NBP2-61719] - Analysis of Hela cells using BUB1 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/Bub1-Antibody-1A11C7-Flow-Cytometry-NBP2-61719-img0002.jpg)
![Western Blot: Bub1 Antibody (1A11C7) [NBP2-61719] - Analysis using BUB1 mAb against HEK293 (1) and BUB1 (AA: 1-130)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/Bub1-Antibody-1A11C7-Western-Blot-NBP2-61719-img0004.jpg)
![ELISA: Bub1 Antibody (1A11C7) [NBP2-61719] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/Bub1-Antibody-1A11C7-ELISA-NBP2-61719-img0001.jpg)
![Western Blot: STYK1 Antibody (2H2F10) [NBP1-47511] - Analysis using STYK1 mouse mAb against truncated STYK1 recombinant protein(1) and STYK1 (aa47-422)-hIgGFc transfected CHO-K1 cell lysate (2).](http://images.novusbio.com/fullsize/STYK1-Antibody-2H2F10-Western-Blot-NBP1-47511-img0007.jpg "Western Blot: STYK1 Antibody (2H2F10) [NBP1-47511] - Analysis using STYK1 mouse mAb against truncated STYK1 recombinant protein(1) and STYK1 (aa47-422)-hIgGFc transfected CHO-K1 cell lysate (2).")
![Immunohistochemistry-Paraffin: STYK1 Antibody (2H2F10) [NBP1-47511] - Analysis of human adrenal tissues using STYK1/NOK mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/STYK1-Antibody-2H2F10-Immunohistochemistry-Paraffin-NBP1-47511-img0006.jpg)
![Immunohistochemistry-Paraffin: STYK1 Antibody (2H2F10) [NBP1-47511] - Analysis of human ovary carcinoma (A), normal cerebrum tissues (B), breast infiltrating carcinoma (C) and breast infiltrating carcinoma (D), showing cytoplasmic localization using STYK1/NOK mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/STYK1-Antibody-2H2F10-Immunohistochemistry-Paraffin-NBP1-47511-img0005.jpg)
![Western Blot: RIPK4 Antibody (1F7D9) [NBP2-61860] - Analysis using RIPK4 mAb against human RIPK4 (AA: 675-784) recombinant protein. (Expected MW is 37.7 kDa)](http://images.novusbio.com/fullsize/RIPK4-Antibody-1F7D9-Western-Blot-NBP2-61860-img0003.jpg "Western Blot: RIPK4 Antibody (1F7D9) [NBP2-61860] - Analysis using RIPK4 mAb against human RIPK4 (AA: 675-784) recombinant protein. (Expected MW is 37.7 kDa)")
![Western Blot: RIPK4 Antibody (1F7D9) [NBP2-61860] - Analysis using RIPK4 mAb against HEK293 (1) and RIPK4 (AA: 675-784)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/RIPK4-Antibody-1F7D9-Western-Blot-NBP2-61860-img0004.jpg)
![ELISA: RIPK4 Antibody (1F7D9) [NBP2-61860] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/RIPK4-Antibody-1F7D9-ELISA-NBP2-61860-img0001.jpg)
![ELISA: RIPK4 Antibody (1F7D9) [NBP2-61860] - Analysis of SK-N-SH cells using RIPK4 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/RIPK4-Antibody-1F7D9-ELISA-NBP2-61860-img0002.jpg)
![Western Blot: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2C1E8) [NBP2-61798] - Analysis using ACVR1 mAb against human ACVR1 (AA: 21-120) recombinant protein. (Expected MW is 37.1 kDa)](http://images.novusbio.com/fullsize/Activin-RIA-ALK-2-Activin-Receptor-Type-1-Antibody-2C1E8-Western-Blot-NBP2-61798-img0003.jpg "Western Blot: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2C1E8) [NBP2-61798] - Analysis using ACVR1 mAb against human ACVR1 (AA: 21-120) recombinant protein. (Expected MW is 37.1 kDa)")
![Flow Cytometry: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2C1E8) [NBP2-61798] - Analysis of Hela cells using ACVR1 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/Activin-RIA-ALK-2-Activin-Receptor-Type-1-Antibody-2C1E8-Flow-Cytometry-NBP2-61798-img0002.jpg)
![Western Blot: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2C1E8) [NBP2-61798] - Analysis using ACVR1 mAb against HEK293 (1) and ACVR1 (AA: 21-120)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/Activin-RIA-ALK-2-Activin-Receptor-Type-1-Antibody-2C1E8-Western-Blot-NBP2-61798-img0004.jpg)
![ELISA: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2C1E8) [NBP2-61798] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/Activin-RIA-ALK-2-Activin-Receptor-Type-1-Antibody-2C1E8-ELISA-NBP2-61798-img0001.jpg)
![Western Blot: NEK11 Antibody (OTI5D9) - Azide and BSA Free [NBP2-72935] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NEK11 cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NEK11.](http://images.novusbio.com/fullsize/NEK11-Antibody-OTI5D9-Azide-and-BSA-Free-Western-Blot-NBP2-72935-img0001.jpg "Western Blot: NEK11 Antibody (OTI5D9) - Azide and BSA Free [NBP2-72935] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NEK11 cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NEK11.")
![Immunocytochemistry/Immunofluorescence: NEK11 Antibody (OTI5D9) - Azide and BSA Free [NBP2-72935] - Analysis of COS7 cells transiently transfected by pCMV6-ENTRY NEK11.](http://images.novusbio.com/fullsize/NEK11-Antibody-OTI5D9-Azide-and-BSA-Free-Immunocytochemistry-Immunofluorescence-NBP2-72935-img0002.jpg)
![Western Blot: TrkA Antibody (OTI5B6) - Azide and BSA Free [NBP2-74623] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TrkA.](http://images.novusbio.com/fullsize/TrkA-Antibody-OTI5B6-Azide-and-BSA-Free-Western-Blot-NBP2-74623-img0001.jpg "Western Blot: TrkA Antibody (OTI5B6) - Azide and BSA Free [NBP2-74623] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TrkA.")
![Immunohistochemistry: TrkA Antibody (OTI5B6) - Azide and BSA Free [NBP2-74623] - Analysis of Carcinoma of Human pancreas tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/TrkA-Antibody-OTI5B6-Azide-and-BSA-Free-Immunohistochemistry-NBP2-74623-img0002.jpg)
![Western Blot: Mark3 Antibody (OTI2G8) - Azide and BSA Free [NBP2-72590] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MARK3.](http://images.novusbio.com/fullsize/Mark3-Antibody-OTI2G8-Azide-and-BSA-Free-Western-Blot-NBP2-72590-img0002.jpg "Western Blot: Mark3 Antibody (OTI2G8) - Azide and BSA Free [NBP2-72590] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MARK3.")
![Western Blot: Mark3 Antibody (OTI2G8) - Azide and BSA Free [NBP2-72590] - Analysis of extracts (10ug) from 2 different cell lines.](http://images.novusbio.com/fullsize/Mark3-Antibody-OTI2G8-Azide-and-BSA-Free-Western-Blot-NBP2-72590-img0001.jpg)
![Western Blot: FGFR2 Antibody [NB200-642] - Whole extract of HEK-293T cells expressing FGFR-2 were separated on SDS-PAGE and probed with Anti-Fibroblast Growth Factor Receptor-2, Cytoplasmic antibody produced in Rabbit. The antibody was developed using 1:10,000 Goat Anti-Rabbit IgG-Peroxidase.Lanes:1. 0.5 ug/mL antibody2. 0.25 ug/mL antibody3. 0.5 ug/mL antibody untransfected 293T cells4. Negative Control](http://images.novusbio.com/fullsize/FGFR2-Antibody-Western-Blot-NB200-642-img0002.jpg "Western Blot: FGFR2 Antibody [NB200-642] - Whole extract of HEK-293T cells expressing FGFR-2 were separated on SDS-PAGE and probed with Anti-Fibroblast Growth Factor Receptor-2, Cytoplasmic antibody produced in Rabbit. The antibody was developed using 1:10,000 Goat Anti-Rabbit IgG-Peroxidase.Lanes:1. 0.5 ug/mL antibody2. 0.25 ug/mL antibody3. 0.5 ug/mL antibody untransfected 293T cells4. Negative Control")
![Immunohistochemistry: FGFR2 Antibody [NB200-642] - Formalin fixed, paraffin-embedded Human placenta tissue sections were stained with 2 ug/mL Anti-Fibroblast Growth Factor Receptor-2, Cytoplasmic antibody produced in Rabbit followed by 20 ug/mL Anti-Rabbit IgG (whole molecule)-Biotin antibody produced in Goat and by 20 ug/mL ExtrAvidin-Peroxidase.](http://images.novusbio.com/fullsize/FGFR2-Antibody-Immunohistochemistry-NB200-642-img0003.jpg)
![Western Blot: FGFR2 Antibody [NB200-642] - Antibody recognition: Anti-Fibroblast Growth Factor Receptor-2, Cytoplasmic antibody produced in Rabbit is confirmed by western blot in the cell sample that has been altered to overexpress the target protein-HEK-293T over expressing Fibroblast Growth Factor Receptor-2 (Lane 1) while no staining is detected in the wild type sample-HEK-293T (Lane 2). The antibody was developed with 1:10,000 Goat Anti-Rabbit IgG-peroxidase and a chemiluminescent substrate.Antibody dilution: 0.5 ug/mL.](http://images.novusbio.com/fullsize/FGFR2-Antibody-Western-Blot-NB200-642-img0001.jpg)
![Western Blot: FGFR3 Antibody [NB600-1509] - Western blot analysis of apoptotic markers following 24 and 48 hrs of selenite (5 uM), GS-Se-SG (5 uM) and Se-DL-cystine (100 uM) treatment. Image collected and cropped by CiteAb from the following publication (onlinelibrary.wiley.com/doi/full/10.1111/jcmm.12214), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/FGFR3-Antibody-Western-Blot-NB600-1509-img0001.jpg "Western Blot: FGFR3 Antibody [NB600-1509] - Western blot analysis of apoptotic markers following 24 and 48 hrs of selenite (5 uM), GS-Se-SG (5 uM) and Se-DL-cystine (100 uM) treatment. Image collected and cropped by CiteAb from the following publication (onlinelibrary.wiley.com/doi/full/10.1111/jcmm.12214), licensed under a CC-BY license.")
![Western Blot: FGFR3 Antibody [NB600-1509] - (A) Western blot analysis of apoptotic markers following 24 & 48 hrs of selenite (5 μM), GS-Se-SG (5 μM) & Se-DL-cystine (100 μM) treatment. (B) Western blot analysis of autophagic & ER stress markers, evaluated after 1, 3, 6 & 18 hrs of treatment with selenite (5 μM), GS-Se-SG (5 μM) & Se-DL-cystine (100 μM). (C) Acridine orange staining of cells after 12 hrs of treatment with selenite (5 μM), GS-Se-SG (5 μM) & Se-DL-cystine (100 μM) (magnification 40 ×). (D) High-resolution transmission electron microscopy micrographs of control & 24 hrs Se-DL-cystine-treated cells, showing the presence of autophagosome, as evident from double-layered membrane structure with inclusion bodies. (E) Western blot detection of ubiquitinylated proteins after treatments with different selenium compounds (similar doses as previous) for 6 hrs. Five microgram cell lysate was loaded into each lane. The lane intensity was analysed by using Adobe Photoshop program (version CS5). beta -actin was used as a loading control (Fig. 4A & B). C: Control; 1: selenite; 2: GS-Se-SG; 3: Se-DL-cystine. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/24400844), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb600-1509_rabbit-polyclonal-fgfr3-antibody-310202416175253.jpg)
![Immunoprecipitation: DYRK1A Antibody [NBP3-30799] - Immunoprecipitation ofDyrk from 293T transfected cells. Immunoprecipitation with- 1) control Ab, 2)Anti-MNP 2 ug/ml, 3)Novus Biologicals' anti-Dyrk 2ug/ml, 4) Novus Biologicals'-Dyrk 10 ug/ml, 5)competitor’s anti-Dyrk Ab 10 ug/ml, Western blot performed with Novus Biologicals' anti-Dyrk Ab at 2 ug/ml.](http://images.novusbio.com/fullsize/nbp3-30799_sheep-dyrk1a-pab-811202420592172.jpg "Immunoprecipitation: DYRK1A Antibody [NBP3-30799] - Immunoprecipitation ofDyrk from 293T transfected cells. Immunoprecipitation with- 1) control Ab, 2)Anti-MNP 2 ug/ml, 3)Novus Biologicals' anti-Dyrk 2ug/ml, 4) Novus Biologicals'-Dyrk 10 ug/ml, 5)competitor’s anti-Dyrk Ab 10 ug/ml, Western blot performed with Novus Biologicals' anti-Dyrk Ab at 2 ug/ml.")
![Immunocytochemistry/Immunofluorescence: ErbB2/Her2 Antibody (511) [NBP2-89187] - Staining of Human ErbB2 in SKBR3 cells. Cells were fixed with 4% PFA, blocked with 10% serum, and incubated with Rabbit anti-Human ErbB2 monoclonal antibody (1:100) at 4c overnight. Then cells were stained with the Alexa Fluor (R) 488-conjugated Goat Anti-rabbit IgG secondary antibody (green) and counterstained with DAPI (blue). Positive staining was localized to plasma membrane.](http://images.novusbio.com/fullsize/ErbB2-Her2-Antibody-511-Immunocytochemistry-Immunofluorescence-NBP2-89187-img0001.jpg "Immunocytochemistry/Immunofluorescence: ErbB2/Her2 Antibody (511) [NBP2-89187] - Staining of Human ErbB2 in SKBR3 cells. Cells were fixed with 4% PFA, blocked with 10% serum, and incubated with Rabbit anti-Human ErbB2 monoclonal antibody (1:100) at 4c overnight. Then cells were stained with the Alexa Fluor (R) 488-conjugated Goat Anti-rabbit IgG secondary antibody (green) and counterstained with DAPI (blue). Positive staining was localized to plasma membrane.")
![Flow Cytometry: ErbB2/Her2 Antibody (511) [NBP2-89187] - Analysis of anti-ErbB2 on MCF-7 cells. MCF-7 cells were detached using 1X trypsin, washed, then stained with purified rabbit anti-human ErbB2. Second step staining with FITC conjugated goat anti-rabbit IgG (H+L) polyclonal antibody.](http://images.novusbio.com/fullsize/ErbB2-Her2-Antibody-511-Flow-Cytometry-NBP2-89187-img0003.jpg)
![Flow Cytometry: ErbB2/Her2 Antibody (511) [NBP2-89187] - Analysis of anti-ErbB2 on SK-BR3 cells. SK-BR3 cells were detached using 1X trypsin, washed, then stained with Purified Rabbit anti-Human ErbB2. Second step staining with FITC conjugated Goat anti-Rabbit IgG polyclonal antibody (BD Pharmingen (R).](http://images.novusbio.com/fullsize/ErbB2-Her2-Antibody-511-Flow-Cytometry-NBP2-89187-img0002.jpg)
![Immunohistochemistry-Paraffin: MKK4/MEK4 Antibody [NBP2-99331] - Immunochemical staining of human MKK4/MEK4 in human skeletal muscle with rabbit polyclonal antibody at 1:1000 dilution, formalin-fixed paraffin embedded sections.](http://images.novusbio.com/fullsize/MKK4-MEK4-Antibody-Immunohistochemistry-Paraffin-NBP2-99331-img0003.jpg "Immunohistochemistry-Paraffin: MKK4/MEK4 Antibody [NBP2-99331] - Immunochemical staining of human MKK4/MEK4 in human skeletal muscle with rabbit polyclonal antibody at 1:1000 dilution, formalin-fixed paraffin embedded sections.")
![Immunohistochemistry-Paraffin: MKK4/MEK4 Antibody [NBP2-99331] - Immunochemical staining of human MKK4/MEK4 in human breast carcinoma with rabbit polyclonal antibody at 1:1000 dilution, formalin-fixed paraffin embedded sections.](http://images.novusbio.com/fullsize/MKK4-MEK4-Antibody-Immunohistochemistry-Paraffin-NBP2-99331-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: MKK4/MEK4 Antibody [NBP2-99331] - Immunofluorescence staining of MKK4/MEK4 in HeLa cells. Cells were fixed with 4% PFA, permeabilzed with 0.3% Triton X-100 in PBS, blocked with 10% serum, and incubated with NBP2-99331 antibody (dilution ratio 1:1000) at 4C overnight. Then cells were stained with the Alexa Fluor$488-conjugated Goat Anti-rabbit IgG Secondary antibody (green). Positive staining was localized to cytoplasm and nucleus.](http://images.novusbio.com/fullsize/nbp2-99331_rabbit-polyclonal-mkk4-mek4-antibody-23520252145179.png)